nach oben

Neurological Sciences

Erschienen in:

01.05.2011 | Migraine and Depression

Migraine and depression: common pathogenetic and therapeutic ground?

verfasst von: F. Moschiano, D. D’Amico, I. Canavero, I. Pan, G. Micieli, G. Bussone

Erschienen in: Neurological Sciences | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Migraine and depression are recognized as comorbid disorders on the basis of several epidemiological data and on the possibility of shared mechanisms. On the other hand, there is a lack of studies concerning therapeutic strategies in patients with this comorbidity. The aim of this paper is to briefly review the literature about the migraine and depression comorbidity and on the putative common neurobiological mechanisms, as well to discuss the possible therapeutic options in treating patients with both disorders.

Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache 46(Suppl 3):S76–S87PubMedCrossRef

Radat F, Swendsen J (2004) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178CrossRef

Lake AE, Rains JC, Penzien DB et al (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493–506PubMedCrossRef

Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333PubMedCrossRef

Breslau N (1998) Psychiatric comorbidity in migraine. Cephalagia 18(Suppl 22):56–61

Baskin SM, Smitherman TA (2009) Migraine and psychiatric disorders: comorbities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61–S65PubMedCrossRef

Finocchi C, Villani V, Casucci G (2010) Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci 31(Suppl 1):S95–S98PubMedCrossRef

Wang SJ, Liu HC, Fuh JL et al (1999) Comorbidity of headaches and depression in the elderly. Pain 82(3):239–243

Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635PubMed

10.

Merikangas KR, Angst J, Isler H (1990) Migraine and psychopatology. Results of Zurich cohort study of young adults. Arch Gen Psychiatry 47:849–853PubMed

11.

Breslau N, Schultz LR, Stewart WF et al (2000) Headache and major depression: is the association specific to migraine? Neurology 54:308–313PubMed

12.

Swartz KL, Pratt LA, Armenian HK et al (2000) Mental disorders and the incidence of migraine headache in a community sample. Arch Gen Psychiatry 57:945–950PubMedCrossRef

13.

Patel NV, Bigal ME, Koloner KB et al (2004) Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63:1432–1438PubMed

14.

Mc Williams LA, Goodwin RD, Cox BJ (2004) Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111:77–83CrossRef

15.

Fasmer OB, Oedegaard KJ (2001) Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry 2:149–155PubMedCrossRef

16.

Oedegaard KJ, Angst J, Neckelmann D et al (2005) Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain 6:378–386PubMedCrossRef

17.

Oedegaard KJ, Neckelmann D, Mykletun A (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The Hunt Study. Cephalalgia 26:1–6PubMedCrossRef

18.

Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression. Neurology 60:1308–1312PubMed

19.

Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 137:11–23CrossRef

20.

Antonaci F, Nappi G, Galli F et al (2011) Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain [Epub ahead of print]

21.

Juhasz G, Zsombok T, Laszik A et al (2003) Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 17:231–240PubMed

22.

Todt U, Freudenberg J, Goebel I et al (2006) Variation of the serotonin receptor gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707–1709PubMedCrossRef

23.

Marziniak M, Mossner R, Schmitt A et al (2005) A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 64:157–159PubMed

24.

Kotani K, Shimomura T, Shimomura F et al (2002) A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42:893–895PubMedCrossRef

25.

Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1295–1300CrossRef

26.

Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305–313

27.

Lotrich FE, Pollock BG (2004) Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Gen 14:121–129CrossRef

28.

Caspi A, Sugden K, Moffit TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389PubMedCrossRef

29.

Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with polymorphisms in the serotonin transporter gene regulatory region. Science 274:1527–1531PubMedCrossRef

30.

Sen s, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127:85–89CrossRef

31.

Perutka SJ, Price SC, Wilhoit TL et al (1998) Comorbid migraine wth aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NNcoI alleles. Mol Med 4:14–21

32.

Seligman MEP (1975) Helplessness: on depression development and death. WH Freeman and Company, San Francisco

33.

Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657PubMedCrossRef

34.

Kessler RC, McGonagle KA, Zhao S (1994) Lifetime and 12-month prevalence of DSM-III R psychiatric disorder in the United States. Results from the National Comorbidity Survey. Arch Gen Psych 51:8–19

35.

Peterlin BL, Katsnelson MJ, Calhoun AH (2009) The association between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep 13(5):404–412PubMedCrossRef

36.

Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis—part I. Headache 46:3–23PubMedCrossRef

37.

Scher AI, Midgette LA, Lipton RRB (2008) Risk factors for headache chronification. Headache 48:16–25PubMedCrossRef

38.

Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343PubMedCrossRef

39.

Smitherman TA, Penzien DB, Maizels M (2008) Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep 12:224–229PubMedCrossRef

40.

Monroe SM, Harkness KL (2005) Life stress, the “kindling” hypothesis, and recurrence of depression: consideration from a life stress perspective. Psychol Rev 112:417–445PubMedCrossRef

41.

Tietjen GE, Brandes JL, Peterlin BL et al (2009) Allodynia in migraine: association with comorbid pain conditions. Hedache 49:1333–1344CrossRef

42.

Lovati C, D’Amico D, Bertora P (2009) Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev Neurother 9(3):395–408PubMedCrossRef

43.

Welch KMA, Nagesh V, Aurora SK et al (2001) Periaquiductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef

44.

Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957–1966PubMedCrossRef

45.

Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185–193PubMed

46.

Peres MF, Sanchez DR, Seabra ML et al (2001) Hypotalamic involment in chronic migraine. J Neurol Neurosurg Psychiatry 71:747–751PubMedCrossRef

47.

Bigal ME, Lipton RB, Holland PR et al (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRef

48.

Miura H, Ozaki N, Sawada M et al (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198–209PubMedCrossRef

49.

Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(suppl 3):S98–S109PubMedCrossRef

50.

Heckman BD, Holroyd KA, Himawan L et al (2009) Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain 146:56–64PubMedCrossRef

51.

Smitherman TA, Walters AB, Maizels M et al (2010) The use of antidepressants for headache prophylaxis. CNS Neurosci Ther 1–8

52.

Evers S (2008) Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother 9(15):2565–2573PubMedCrossRef

53.

Colombo B, Annovazzi POL, Comi G (2004) Therapy of primary hedaches: the role of antidepressant. Neurol Sci 25:S171–S175PubMedCrossRef

54.

Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS, European Federation of Neurological Societies (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16(9):968–981PubMedCrossRef

55.

Proietti Cecchin A, Mea E, Tullo V et al (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30(Suppl 1):S101–S104CrossRef

56.

Nahas Z, Marangell LB, Husain MM et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104PubMedCrossRef

Titel: Migraine and depression: common pathogenetic and therapeutic ground?
verfasst von: F. Moschiano
D. D’Amico
I. Canavero
I. Pan
G. Micieli
G. Bussone
Publikationsdatum: 01.05.2011
Verlag: Springer Milan
Erschienen in: Neurological Sciences / Ausgabe Sonderheft 1/2011
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-011-0545-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2011

The role of the visual system in migraine: an update

Acupuncture in primary headache treatment

Neuromodulation in drug-resistant primary headaches: what have we learned?

Psychopathological profile of patients with chronic migraine and medication overuse: study and findings in 50 cases

Consultation-liaison psychiatry for patients with headaches